1. Spiekerkoetter, E, Kawut, SM, de Jesus Perez, VA. New and emerging therapies for pulmonary arterial hypertension. Ann Rev Med 2019; 70: 45–59.
Google Scholar | Crossref | Medline2. Mc Laughlin, VV, Hoeper, MM, Channick, RN, et al. Pulmonary arterial hypertension-related morbidity is prognostic for mortality. J Am Coll Cardiol 2018; 71: 752–763.
Google Scholar | Crossref | Medline3. Sitbon, O, Humbert, M, Jais, X, et al. Longterm response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005; 111: 3105–3111.
Google Scholar | Crossref | Medline | ISI4. Arena, R, Lavie, CJ, Milani Ross, RV, et al. Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review. J Heart Lung Transplant 2010; 29: 159–173.
Google Scholar | Crossref | Medline | ISI5. Sun, XG, Hansen, JE, Oudiz, RJ. Exercise pathophysiology inpatients with primary pulmonary hypertension. Circulation 2001; 104: 429–435.
Google Scholar | Crossref | Medline | ISI6. Chen, TX, Pudasaini, B, Guo, J, et al. Sex-specific cardiopulmonary exercise testing indices to estimate the severity of inoperable chronic thromboembolic pulmonary hypertension. Int J Chron Obstruct Pulmonary Dis 2018; 13: 385–397.
Google Scholar | Crossref | Medline7. Zhao, QH, Wu, WH, Gong, SG, et al . Cardiopulmonary exercise testing improves diagnostic specificity in patients with echocardiography-suspected pulmonary hypertension. Zhong Hua Jie He Hu Xi Za Zhi 2018; 41: 41–46.
Google Scholar | Medline8. Yuan, P, Ni, HJ, Chen, TX, et al. Sex-specific cardiopulmonary exercise testing indices related to hemodynamics in idiopathic pulmonary arterial hypertension. Hyper Res 2017; 40: 868–875.
Google Scholar | Crossref | Medline9. Galie,  ` N, Humbert, M, Vachiery, JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015; 46: 903–975.
Google Scholar | Crossref | Medline | ISI10. Pellegrino, R, Viegi, G, Brusasco, V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948–968.
Google Scholar | Crossref | Medline | ISI11. Zheng, J and, Zhong, N. Normative values of pulmonary function testing in Chinese adults. Chin Med J 2002; 115: 50–54.
Google Scholar | Medline12. American Thoracic Society; American College of Chest Physicians . ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167: 211–277.
Google Scholar | Crossref | Medline | ISI13. Beaver, WL, Wasserman, K, Whipp, BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986; 60: 2020–2027.
Google Scholar | Crossref | Medline | ISI14. Sun, XG, Hansen, JE, Garatachea, N, et al. Ventilatory efficiency during exercise in healthy subjects. Am J Respir Crit Care Med 2002; 166: 1443–1448.
Google Scholar | Crossref | Medline | ISI15. Baba, R, Nagashima, M, Goto, M, et al. Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between 25 oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol 1996; 28: 1567–1572.
Google Scholar | Crossref | Medline | ISI16. Sun, XG, Hansen, JE, Stringer, WW, et al. Oxygen uptake efficiency plateau (OUEP): physiology and reference value. Eur J Appl Physiol 2012; 112: 919–928.
Google Scholar | Crossref | Medline | ISI17. Rubin, LJ, Groves, BM, Reeves, JT, et al. Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension. Circulation 1982; 66: 334–338.
Google Scholar | Crossref | Medline | ISI18. Nootens, M, Schrader, B, Kaufmann, E, et al. Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension. Chest 1995; 107: 54–57.
Google Scholar | Crossref | Medline | ISI19. Sitbon, O, Humbert, M, Jagot, JL, et al. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium channel blockers in primary pulmonary hypertension. Eur Respir J 1998; 12: 265–270.
Google Scholar | Crossref | Medline | ISI20. Barst, RJ, Maislin, G, Fishman, AP, et al. Vasodilator therapy for primary pulmonary hypertension in children. Circulation 1999; 99: 1197–1208.
Google Scholar | Crossref | Medline | ISI21. Raffy, O, Azarian, R, Brenot, F, et al. Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension. Circulation 1996; 93: 484–488.
Google Scholar | Crossref | Medline | ISI22. Galie, N, Hoeper, MM, Humbert, M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS), endorsed by the international society of heart and lung transplantation (ISHLT). Eur Heart J 2009; 30: 2493–2537.
Google Scholar | Crossref | Medline | ISI23. Gali, N, Torbieki, A, Barst, R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004; 25: 2243–2278.
Google Scholar | Crossref | Medline24. McLaughlin, VV, Archer, SL, Badesch, DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc, and the Pulmonary Hypertension Association. Circulation 2009; 119: 2250–2294.
Google Scholar | Crossref | Medline | ISI25. Brittain, EL, Hemnes, AR. Vasodilator-responsive idiopathic pulmonary arterial hypertension: evidence for a new disease? Ann Intern Med 2015; 162: 148–149.
Google Scholar | Crossref | Medline | ISI26. Langleben, D, Orfanos, SE, Giovinazzo, M, et al. Acute vasodilator responsiveness and microvascular recruitment in idiopathic pulmonary arterial hypertension. Ann Intern Med 2015; 162: 154–156.
Google Scholar | Crossref | Medline | ISI27. Rocco, EA, Prado, DML, Silva, AG, et al. Effect of continuous and interval exercise training on the PETCO2 response during a graded exercise test in patients with coronary artery disease. Clinics 2012; 67: 623–627.
Google Scholar | Crossref | Medline | ISI28. Matsumoto, A, Itoh, H, Eto, Y, et al. End-tidal CO2 pressure decreases during exercise in cardiac patients: association with severity of heart failure and cardiac output reserve. J Am Coll Cardio 2000; 36: 242–249.
Google Scholar | Crossref | Medline | ISI29. Yasunobu, Y, Oudiz, RJ, Sun, XG, et al. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest 2005; 127: 1637–1646.
Google Scholar | Crossref | Medline | ISI30. Ferrazza, AM, Martolini, D, Valli, G, et al. Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration 2009; 77: 3–17.
Google Scholar | Crossref | Medline31. Tang, Y, Yao, L, Liu, ZH, et al. Effect of calcium channel blockers evaluated by cardiopulmonary exercise testing in idiopathic pulmonary arterial hypertension responding to acute pulmonary vasoreactivity testing. Pulmon Pharmacol Therap 2017; 43: 26–31.
Google Scholar | Crossref | Medline